{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:55:55Z","timestamp":1791914155119,"version":"4.3.4"},"reference-count":213,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Aging and major chronic diseases are risk factors for lower urinary tract symptoms (LUTS). On the other hand, oxidative stress (OS) is one of the fundamental mechanisms of aging and the development of chronic diseases. Therefore, OS might be a candidate mechanism linking these two clinical entities. This article aims to summarize the studies on the prevalence of LUTS, the role of OS in aging and chronic diseases, and the potential mechanisms supporting the putative link. A comprehensive literature search was performed to identify recent reports investigating LUTS and OS in major chronic diseases. In addition, studies on the impact of OS on the lower urinary tract, including bladder, urethra, and prostate, were collected and summarized. Many studies showed LUTS are prevalent in aging and major chronic diseases, including obesity, metabolic syndrome, diabetes, cardiovascular disease, hypertension, obstructive sleep apnea, autoimmune diseases, Alzheimer\u2019s disease, and Parkinson\u2019s disease. At the same time, OS is a key component in the pathogenesis of those chronic diseases and conditions. Recent studies also provided evidence that exacerbated OS can cause functional and\/or structural changes in the bladder, urethra, and prostate, leading to LUTS. The reviewed data support the concept that OS is involved in multiple risk factors-associated LUTS, although further studies are needed to confirm the causative relationship. The specific ROS\/RNS and corresponding reactions\/pathways involved in chronic diseases and associated LUTS should be identified in the future and could serve as therapeutic targets.<\/jats:p>","DOI":"10.3389\/fmed.2022.812967","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:06:37Z","timestamp":1646906797000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Oxidative Stress: A Putative Link Between Lower Urinary Tract Symptoms and Aging and Major Chronic Diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhenqun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania A.","family":"Elrashidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76846-0","article-title":"Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study.","volume":"10","author":"Przydacz","year":"2020","journal-title":"Sci Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/jwh.2017.6566","article-title":"The prevention of lower urinary tract symptoms (PLUS) research consortium: a transdisciplinary approach toward promoting bladder health and preventing lower urinary tract symptoms in women across the life course.","volume":"27","author":"Harlow","year":"2018","journal-title":"J Womens Health (Larchmt)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/nau.23828","article-title":"Prevalence of lower urinary tract symptoms and overactive bladder in men and women over 18 years old: the Colombian overactive bladder and lower urinary tract symptoms (COBaLT) study.","volume":"38","author":"Plata","year":"2019","journal-title":"Neurourol Urodyn."},{"key":"B4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.eururo.2009.02.026","article-title":"Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.","volume":"56","author":"Irwin","year":"2009","journal-title":"Eur Urol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the international continence society.","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/MOU.0000000000000283","article-title":"Lower urinary tract symptoms in women: epidemiology, diagnosis, and management.","volume":"26","author":"Cox","year":"2016","journal-title":"Curr Opin Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MOU.0b013e32832b659d","article-title":"Lower urinary tract symptoms in women.","volume":"19","author":"Milsom","year":"2009","journal-title":"Curr Opin Urol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/j.1464-410X.2006.06525.x","article-title":"Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: results of a regional population-based survey and comparison with industrialized nations.","volume":"98","author":"Mariappan","year":"2006","journal-title":"BJU Int."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1493","article-title":"Lower urinary tract symptoms in an older man.","volume":"357","author":"Vedanayagam","year":"2017","journal-title":"BMJ."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2016.00159","article-title":"Use your words carefully: what is a chronic disease?","volume":"4","author":"Bernell","year":"2016","journal-title":"Front Public Health."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15030431","article-title":"An empirical study of chronic diseases in the United States: a visual analytics approach.","volume":"15","author":"Raghupathi","year":"2018","journal-title":"Int J Environ Res Public Health."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/ggi.12048","article-title":"Prevalence of lower urinary tract symptoms in middle-aged and elderly Japanese.","volume":"13","author":"Osuga","year":"2013","journal-title":"Geriatr Gerontol Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000437336","article-title":"Lower urinary tract symptoms and aging: the impact of chronic bladder ischemia on overactive bladder syndrome.","volume":"95","author":"Camoes","year":"2015","journal-title":"Urol Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.urology.2016.06.023","article-title":"Population-level and individual-level bother of lower urinary tract symptoms among 30- to 80-year-old men.","volume":"95","author":"Poyhonen","year":"2016","journal-title":"Urology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/luts.12078","article-title":"Survey and risk factors for lower urinary tract storage symptoms in middle-aged and older stroke patients in urban China.","volume":"8","author":"Tian","year":"2016","journal-title":"Lower Urinary Tract Symp."},{"key":"B16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/nau.23035","article-title":"Can we define and characterize the aging lower urinary tract?-ICI-RS 2015.","volume":"36","author":"Vahabi","year":"2017","journal-title":"Neurourol Urodyn."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/bju.13038","article-title":"Does metabolic syndrome increase erectile dysfunction and lower urinary tract symptoms.","volume":"11","author":"Coban","year":"2014","journal-title":"Urol J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.juro.2013.08.110","article-title":"A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms.","volume":"191","author":"Mondul","year":"2014","journal-title":"J Urol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.soard.2017.01.047","article-title":"Improvement of voiding characteristics in morbidly obese women after bariatric surgery: a single-center study with a 1-year follow-up.","volume":"13","author":"Kim","year":"2017","journal-title":"Surg Obes Relat Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.soard.2016.04.027","article-title":"Association between obesity and lower urinary tract symptoms: propensity score matching study between healthy controls and obese patients seeking bariatric surgery.","volume":"12","author":"Kim","year":"2016","journal-title":"Surg Obes Relat Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/nau.22980","article-title":"Effects of bariatric surgery on male lower urinary tract symptoms and sexual function.","volume":"36","author":"Groutz","year":"2017","journal-title":"Neurourol Urodyn."},{"key":"B22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/bju.14007","article-title":"Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).","volume":"121","author":"Russo","year":"2018","journal-title":"BJU Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/21681805.2017.1354912","article-title":"Association between metabolic syndrome and overactive bladder: a case-control study.","volume":"51","author":"Saratlija Novakovic","year":"2017","journal-title":"Scand J Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajur.2017.05.001","article-title":"Metabolic syndrome and benign prostatic hyperplasia: an update.","volume":"4","author":"Ngai","year":"2017","journal-title":"Asian J Urol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/nau.22765","article-title":"Lower urinary tract symptoms and metabolic disorders: ICI-RS 2014.","volume":"35","author":"Denys","year":"2016","journal-title":"Neurourol Urodyn."},{"key":"B26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.acuro.2016.12.009","article-title":"Prevalence of metabolic syndrome and its association with lower urinary tract symptoms and sexual function.","volume":"41","author":"Plata","year":"2017","journal-title":"Actas Urol Esp."},{"key":"B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urology.2017.03.040","article-title":"The relationship between diabetes, diabetes severity, diabetes biomarkers, and the presence of lower urinary tract symptoms: findings from the national health and nutrition examination survey.","volume":"105","author":"Tam","year":"2017","journal-title":"Urology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jdiacomp.2016.01.002","article-title":"Associations between lower urinary tract dysfunction and glycemic control in women with type 2 diabetes: a cross-sectional study.","volume":"30","author":"Tai","year":"2016","journal-title":"J Diabetes Complications."},{"key":"B29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/WON.0000000000000259","article-title":"Lower urinary tract symptoms in women with type 2 Diabetes mellitus.","volume":"43","author":"Dereli Yilmaz","year":"2016","journal-title":"J Wound Ostomy Continence Nurs."},{"key":"B30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrurol.2015.301","article-title":"Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.","volume":"13","author":"Vignozzi","year":"2016","journal-title":"Nat Rev Urol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/luts.12102","article-title":"Correlation between advanced glycation end-products, lower urinary tract symptoms and bladder dysfunctions in patients with type 2 diabetes mellitus.","volume":"9","author":"Gali","year":"2017","journal-title":"Lower Urinary Tract Symptoms."},{"key":"B32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.juro.2008.10.039","article-title":"Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration\u2013results from the BACH Survey.","volume":"181","author":"Kupelian","year":"2009","journal-title":"J Urol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.juro.2014.08.097","article-title":"Association of moderate to severe lower urinary tract symptoms with incident type 2 diabetes and heart disease.","volume":"193","author":"Kupelian","year":"2015","journal-title":"J Urol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.eururo.2016.07.007","article-title":"Male lower urinary tract symptoms and cardiovascular events: a systematic review and meta-analysis.","volume":"70","author":"Gacci","year":"2016","journal-title":"Eur Urol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.urology.2011.05.065","article-title":"Is there an association between lower urinary tract symptoms and cardiovascular risk in men? A cross sectional and longitudinal analysis.","volume":"78","author":"Wehrberger","year":"2011","journal-title":"Urology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.eururo.2016.07.030","article-title":"Male lower urinary tract symptoms reveal and predict important cardiovascular disease.","volume":"70","author":"Fode","year":"2016","journal-title":"Eur Urol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/luts.12046","article-title":"Men with hypertension are more likely to have severe lower urinary tract symptoms and large prostate volume.","volume":"7","author":"Hwang","year":"2015","journal-title":"Lower Urinary Tract Symptoms."},{"key":"B38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1757-5672.2011.00115.x","article-title":"Male lower urinary tract symptoms: hypertension as a risk factor for storage symptoms, but not voiding symptoms.","volume":"4","author":"Ito","year":"2012","journal-title":"Lower Urinary Tract Symptoms."},{"key":"B39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1046\/j.1442-2042.2003.00707.x","article-title":"Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia.","volume":"10","author":"Sugaya","year":"2003","journal-title":"Int J Urol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.sleep.2005.10.004","article-title":"Nocturia in sleep-disordered breathing.","volume":"7","author":"Oztura","year":"2006","journal-title":"Sleep Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.urology.2008.02.038","article-title":"Nocturia in men less than 50 years of age may be associated with obstructive sleep apnea syndrome.","volume":"71","author":"Moriyama","year":"2008","journal-title":"Urology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/0974-7796.127019","article-title":"Clinical predictors of nocturia in the sleep apnea population.","volume":"6","author":"Raheem","year":"2014","journal-title":"Urol Ann."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11325-016-1336-x","article-title":"Obstructive sleep apnea and urological comorbidities in males: a population-based study.","volume":"20","author":"Chung","year":"2016","journal-title":"Sleep Breath."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1253\/circj.CJ-15-0654","article-title":"Nocturia in patients with sleep-disordered breathing and cardiovascular disease.","volume":"79","author":"Miyazaki","year":"2015","journal-title":"Circ J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.urology.2018.08.001","article-title":"Evaluation of sexual dysfunction, lower urinary tract symptoms and quality of life in men with obstructive sleep Apnea syndrome and the efficacy of continuous positive airway pressure therapy.","volume":"121","author":"Irer","year":"2018","journal-title":"Urology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3906\/sag-1210-20","article-title":"The association of nocturia with sleep disorders and metabolic and chronic pulmonary conditions: data derived from the polysomnographic evaluations of 730 patients.","volume":"44","author":"Ayik","year":"2014","journal-title":"Turk J Med Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s001920050075","article-title":"Lower urinary tract symptoms in patients with Sjogren\u2019s syndrome and systemic lupus erythematosus.","volume":"11","author":"Haarala","year":"2000","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/ene.13010","article-title":"Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients\u2019 quality of life.","volume":"23","author":"Zecca","year":"2016","journal-title":"Eur J Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5489\/cuaj.4058","article-title":"Evaluation of lower urinary tract symptoms in multiple sclerosis patients: review of the literature and current guidelines.","volume":"11","author":"Aharony","year":"2017","journal-title":"Can Urol Assoc J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0961203318811605","article-title":"Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjogren syndrome.","volume":"28","author":"Pereira","year":"2019","journal-title":"Lupus."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1111\/jgs.12004","article-title":"White matter lesions or Alzheimer\u2019s disease: which contributes more to overactive bladder and incontinence in elderly adults with dementia?","volume":"60","author":"Takahashi","year":"2012","journal-title":"J Am Geriatr Soc."},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/appy.12007","article-title":"Urinary incontinence in Alzheimer\u2019s disease is associated with clinical dementia rating-sum of boxes and barthel activities of daily living.","volume":"7","author":"Na","year":"2015","journal-title":"Asia Pac Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1590\/s1677-5538.ibju.2015.0664","article-title":"Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer\u2019s disease patients with lower urinary tract symptom.","volume":"43","author":"Jung","year":"2017","journal-title":"Int Braz J Urol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/JNN.0b013e3182a3cf67","article-title":"Lower urinary tract symptoms in men with Parkinson disease.","volume":"45","author":"Robinson","year":"2013","journal-title":"J Neurosci Nurs."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1080\/00207454.2017.1327857","article-title":"Management of lower urinary tract symptoms in Parkinson\u2019s disease in the neurology clinic.","volume":"127","author":"Madan","year":"2017","journal-title":"Int J Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1442-2042.2012.03220.x","article-title":"Effective management of lower urinary tract dysfunction in idiopathic Parkinson\u2019s disease.","volume":"20","author":"Kapoor","year":"2013","journal-title":"Int J Urol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/nau.23301","article-title":"Does deep brain stimulation improve lower urinary tract symptoms in Parkinson\u2019s disease?","volume":"37","author":"Witte","year":"2018","journal-title":"Neurourol Urodyn."},{"key":"B58","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","article-title":"Targeting free radicals in oxidative stress-related human diseases.","volume":"38","author":"Poprac","year":"2017","journal-title":"Trends Pharmacol Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease.","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","article-title":"Geroscience: linking aging to chronic disease.","volume":"159","author":"Kennedy","year":"2014","journal-title":"Cell."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","article-title":"Urologic diseases in America project: benign prostatic hyperplasia.","volume":"173","author":"Wei","year":"2005","journal-title":"J Urol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2008.03.057","article-title":"Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years.","volume":"72","author":"Parsons","year":"2008","journal-title":"Urology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.urology.2006.04.019","article-title":"Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study.","volume":"68","author":"Taylor","year":"2006","journal-title":"Urology."},{"key":"B64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5213\/inj.2014.18.3.126","article-title":"The prevalence of lower urinary tract symptoms in korean men aged 40 years or older: a population-based survey.","volume":"18","author":"Kim","year":"2014","journal-title":"Int Neurourol J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.urology.2016.06.021","article-title":"Prevalence and progression of lower urinary tract symptoms in an aging population.","volume":"95","author":"Rohrmann","year":"2016","journal-title":"Urology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.juro.2013.07.005","article-title":"Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample.","volume":"191","author":"Maserejian","year":"2014","journal-title":"J Urol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/archinte.166.21.2381","article-title":"Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston area community health (BACH) survey.","volume":"166","author":"Kupelian","year":"2006","journal-title":"Arch Intern Med."},{"key":"B68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11934-009-0041-8","article-title":"Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity.","volume":"10","author":"Mongiu","year":"2009","journal-title":"Curr Urol Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1464-410X.2011.10819.x","article-title":"Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms.","volume":"110","author":"Lee","year":"2012","journal-title":"BJU Int."},{"key":"B70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/13685538.2014.967671","article-title":"Waist circumference and risk of lower urinary tract symptoms: a meta-analysis.","volume":"17","author":"He","year":"2014","journal-title":"Aging Male."},{"key":"B71","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/pros.23185","article-title":"Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse model.","volume":"76","author":"He","year":"2016","journal-title":"Prostate."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-016-0620-4","article-title":"The impact of central obesity on storage luts and urinary incontinence after prostatic surgery.","volume":"17","author":"Gacci","year":"2016","journal-title":"Curr Urol Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/SPV.0000000000000802","article-title":"American urogynecologic society systematic review: the impact of weight loss intervention on lower urinary tract symptoms and urinary incontinence in overweight and obese women.","volume":"26","author":"Yazdany","year":"2020","journal-title":"Female Pelvic Med Reconstr Surg."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.juro.2012.10.058","article-title":"Impact of obesity on urinary storage symptoms: results from the FINNO study.","volume":"189","author":"Vaughan","year":"2013","journal-title":"J Urol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.juro.2011.07.067","article-title":"Urologic diseases in America P. Obesity, physical activity and lower urinary tract symptoms: results from the southern community Cohort study.","volume":"186","author":"Penson","year":"2011","journal-title":"J Urol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.juro.2013.02.025","article-title":"Psychosocial comorbidities and obesity are associated with lower urinary tract symptoms in children with voiding dysfunction.","author":"Oliver","year":"2013","journal-title":"J Urol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.juro.2010.10.048","article-title":"The association of adiposity and overactive bladder appears to differ by gender: results from the Boston area community health survey.","volume":"185","author":"Link","year":"2011","journal-title":"J Urol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012.","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA."},{"key":"B79","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/j.juro.2012.11.026","article-title":"Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey.","author":"Kupelian","year":"2013","journal-title":"J Urol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/sj.ijo.0802881","article-title":"Association between markers of the metabolic syndrome and lower urinary tract symptoms in the third national health and nutrition examination survey (NHANES III).","volume":"29","author":"Rohrmann","year":"2005","journal-title":"Int J Obes."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/203854","article-title":"Is metabolic syndrome truly a risk factor for male lower urinary tract symptoms or just an epiphenomenon?","volume":"2014","author":"Zamuner","year":"2014","journal-title":"Adv Urol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12728","article-title":"Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.","volume":"115","author":"Gacci","year":"2015","journal-title":"BJU Int."},{"key":"B83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/pcan.2015.43","article-title":"Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links.","volume":"19","author":"He","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B84","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3760\/cma.j.issn.0366-6999.20132407","article-title":"Diabetic bladder dysfunction.","volume":"127","author":"Liu","year":"2014","journal-title":"Chin Med J (Engl)."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.2337\/dc18-0255","article-title":"Burden of Urological complications in men and women with long-standing type 1 diabetes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications Cohort.","volume":"41","author":"Wessells","year":"2018","journal-title":"Diabetes Care."},{"key":"B86","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11934-009-0044-5","article-title":"Diabetes and benign prostatic hyperplasia: emerging clinical connections.","volume":"10","author":"Sarma","year":"2009","journal-title":"Curr Urol Rep."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-13-12","article-title":"Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study.","volume":"13","author":"Van Den Eeden","year":"2013","journal-title":"BMC Urol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.urology.2014.05.017","article-title":"Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?","volume":"84","author":"Bang","year":"2014","journal-title":"Urology."},{"key":"B89","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.urology.2005.08.010","article-title":"Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.","volume":"67","author":"Burke","year":"2006","journal-title":"Urology."},{"key":"B90","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.juro.2011.10.139","article-title":"Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the look AHEAD trial.","volume":"187","author":"Phelan","year":"2012","journal-title":"J Urol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.2337\/dc07-0262","article-title":"Pelvic floor disorders, diabetes, and obesity in women: findings from the Kaiser permanente continence associated risk epidemiology study.","volume":"30","author":"Lawrence","year":"2007","journal-title":"Diabetes Care."},{"key":"B92","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/nau.20727","article-title":"Urodynamic findings in female diabetic patients with and without overactive bladder symptoms.","volume":"29","author":"Ho","year":"2010","journal-title":"Neurourol Urodyn."},{"key":"B93","doi-asserted-by":"publisher","first-page":"F887","DOI":"10.1152\/ajprenal.00489.2016","article-title":"Path of translational discovery of urological complications of obesity and diabetes.","volume":"312","author":"Daneshgari","year":"2017","journal-title":"Am J Physiol Renal Physiol."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-15-9","article-title":"Are lower urinary tract symptoms in men associated with cardiovascular diseases in a primary care population: a registry study.","volume":"15","author":"Bouwman","year":"2014","journal-title":"BMC Fam Pract."},{"key":"B95","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.eururo.2007.03.014","article-title":"Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses.","volume":"52","author":"Fitzgerald","year":"2007","journal-title":"Eur Urol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00345-015-1560-1","article-title":"Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis.","volume":"33","author":"Bouwman","year":"2015","journal-title":"World J Urol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/nau.20605","article-title":"Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey.","volume":"27","author":"Tibaek","year":"2008","journal-title":"Neurourol Urodyn."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/nau.23206","article-title":"A questionnaire survey to assess lower urinary tract symptoms in patients with chronic stroke.","volume":"36","author":"Miyazato","year":"2017","journal-title":"Neurourol Urodyn."},{"key":"B99","first-page":"1","article-title":"Hypertension prevalence among adults aged 18 and over: United States, 2017-2018.","author":"Ostchega","year":"2020","journal-title":"NCHS Data Brief."},{"key":"B100","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000020162","article-title":"Risk factors for lower urinary tract symptoms in elderly men. For the prostate study group of the Austrian society of urology.","volume":"37","author":"Haidinger","year":"2000","journal-title":"Eur Urol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1442-2042.2004.00791.x","article-title":"Prevalence of and risk factors for nocturia: analysis of a health screening program.","volume":"11","author":"Yoshimura","year":"2004","journal-title":"Int J Urol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.juro.2016.08.087","article-title":"Nocturnal polyuria and hypertension in patients with lifestyle related diseases and overactive bladder.","volume":"197","author":"Yokoyama","year":"2017","journal-title":"J Urol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/pcan.2011.69","article-title":"The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study.","volume":"15","author":"Chong","year":"2012","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/resp.13838","article-title":"Global burden of sleep-disordered breathing and its implications.","volume":"25","author":"Lyons","year":"2020","journal-title":"Respirology."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56050208","article-title":"Obstructive sleep Apnea: a view from the back door.","volume":"56","author":"Dragonieri","year":"2020","journal-title":"Medicina (Kaunas)."},{"key":"B106","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11934-012-0281-x","article-title":"LUTS and sleep disorders: emerging risk factor.","volume":"13","author":"Cakir","year":"2012","journal-title":"Curr Urol Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/nau.22936","article-title":"Effect of continuous positive airway pressure on nocturnal urine production in patients with obstructive sleep apnea syndrome.","volume":"36","author":"Miyazato","year":"2017","journal-title":"Neurourol Urodyn."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050488","article-title":"Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease.","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology."},{"key":"B110","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1533317516680900","article-title":"Urinary incontinence in Alzheimer\u2019s disease.","volume":"32","author":"Lee","year":"2017","journal-title":"Am J Alzheimers Dis Other Demen."},{"key":"B111","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson\u2019s disease: prevalence, aetiology and management.","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B112","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/s0004-282x2003000300007","article-title":"Urinary symptoms in Parkinson\u2019s disease: prevalence and associated factors.","volume":"61","author":"Campos-Sousa","year":"2003","journal-title":"Arq Neuropsiquiatr."},{"key":"B113","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.parkreldis.2003.07.001","article-title":"The risk of bladder and autonomic dysfunction in a community cohort of Parkinson\u2019s disease patients and normal controls.","volume":"10","author":"Hobson","year":"2003","journal-title":"Parkinsonism Relat Disord."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3906\/sag-1507-148","article-title":"Is there a difference between Parkinson disease patients and a control group in terms of urinary symptoms and quality of life?","volume":"46","author":"Benli","year":"2016","journal-title":"Turk J Med Sci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11255-011-9969-y","article-title":"Urinary tract dysfunction in Parkinson\u2019s disease: a review.","volume":"44","author":"Yeo","year":"2012","journal-title":"Int Urol Nephrol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0531-5565(00)00198-4","article-title":"Alterations of antioxidant enzymes and oxidative stress markers in aging.","volume":"36","author":"Kasapoglu","year":"2001","journal-title":"Exp Gerontol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2147\/CIA.S201250","article-title":"Changes in the blood antioxidant defense of advanced age people.","volume":"14","author":"Kozakiewicz","year":"2019","journal-title":"Clin Interv Aging."},{"key":"B118","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2015.05.036","article-title":"Oxidative stress response and Nrf2 signaling in aging.","author":"Zhang","year":"2015","journal-title":"Free Radic Biol Med."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/646354","article-title":"Oxidative stress, mitochondrial dysfunction, and aging.","volume":"2012","author":"Cui","year":"2012","journal-title":"J Signal Transduct."},{"key":"B120","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","article-title":"Oxidative stress, aging, and diseases.","volume":"13","author":"Liguori","year":"2018","journal-title":"Clin Interv Aging."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.108","article-title":"Cell signalling: signalling to cell cycle arrest.","volume":"17","author":"Strzyz","year":"2016","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"10497","DOI":"10.3390\/ijms140510497","article-title":"Obesity-associated oxidative stress: strategies finalized to improve redox state.","volume":"14","author":"Savini","year":"2013","journal-title":"Int J Mol Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000336526","article-title":"Hypocaloric diet and regular moderate aerobic exercise is an effective strategy to reduce anthropometric parameters and oxidative stress in obese patients.","volume":"5","author":"Gutierrez-Lopez","year":"2012","journal-title":"Obes Facts."},{"key":"B124","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/met.2015.0095","article-title":"Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies.","volume":"13","author":"Manna","year":"2015","journal-title":"Metab Syndr Relat Disord."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome.","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Investig."},{"key":"B126","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.lfs.2009.02.026","article-title":"Oxidative stress and metabolic syndrome.","volume":"84","author":"Roberts","year":"2009","journal-title":"Life Sci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/oby.2006.248","article-title":"Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults.","volume":"14","author":"Van Guilder","year":"2006","journal-title":"Obesity (Silver Spring)."},{"key":"B128","doi-asserted-by":"publisher","first-page":"E1844","DOI":"10.1210\/jc.2012-2498","article-title":"Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome.","volume":"97","author":"Jialal","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B129","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1179\/174329211X13049558293713","article-title":"Systemic upregulation of NADPH oxidase in diet-induced obesity in rats.","volume":"16","author":"Jiang","year":"2011","journal-title":"Redox Rep."},{"key":"B130","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.","volume":"89","author":"Hansel","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B131","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000348569","article-title":"Altered activities of antioxidant enzymes in patients with metabolic syndrome.","volume":"6","author":"Vavrova","year":"2013","journal-title":"Obes Facts."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.bbagen.2014.05.017","article-title":"Diabetes, oxidative stress and therapeutic strategies.","volume":"1840","author":"Rochette","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B133","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/JOE-12-0072","article-title":"Reactive oxygen and nitrogen species generation, antioxidant defenses, and beta-cell function: a critical role for amino acids.","volume":"214","author":"Newsholme","year":"2012","journal-title":"J Endocrinol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.clinbiochem.2009.11.011","article-title":"Protein oxidation biomarkers in plasma of type 2 diabetic patients.","volume":"43","author":"Pandey","year":"2010","journal-title":"Clin Biochem."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4323198","article-title":"Elevated levels of urinary markers of oxidative DNA and RNA damage in type 2 diabetes with complications.","volume":"2016","author":"Liu","year":"2016","journal-title":"Oxid Med Cell Longev."},{"key":"B136","doi-asserted-by":"publisher","first-page":"20290","DOI":"10.3390\/ijms151120290","article-title":"Nrf2 and redox status in prediabetic and diabetic patients.","volume":"15","author":"Jimenez-Osorio","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications.","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1515\/CCLM.2011.250","article-title":"Oxidative stress and diabetes mellitus.","volume":"49","author":"Yang","year":"2011","journal-title":"Clin Chem Lab Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4161\/oxim.2.5.9441","article-title":"Oxidative stress as a mediator of cardiovascular disease.","volume":"2","author":"Elahi","year":"2009","journal-title":"Oxid Med Cell Longev."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020022","article-title":"CVD and oxidative stress.","volume":"6","author":"Cervantes Gracia","year":"2017","journal-title":"J Clin Med."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1089\/ars.2013.5607","article-title":"NADPH oxidases in vascular pathology.","volume":"20","author":"Konior","year":"2014","journal-title":"Antioxid Redox Signal."},{"key":"B142","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/cvr\/cvq016","article-title":"The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease.","volume":"86","author":"Poeckel","year":"2010","journal-title":"Cardiovasc Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1755-5922.2011.00277.x","article-title":"Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.","volume":"30","author":"Higgins","year":"2012","journal-title":"Cardiovasc Ther."},{"key":"B144","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1568026611313020004","article-title":"Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease.","volume":"13","author":"Anatoliotakis","year":"2013","journal-title":"Curr Top Med Chem."},{"key":"B145","first-page":"49","article-title":"Oxidative stress status and liver markers in coronary heart disease.","volume":"8","author":"Cheraghi","year":"2019","journal-title":"Rep Biochem Mol Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/CIRCULATIONAHA.115.019790","article-title":"Novel biomarker of oxidative stress is associated with risk of death in patients with coronary artery disease.","volume":"133","author":"Patel","year":"2016","journal-title":"Circulation."},{"key":"B147","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2015.05.016","article-title":"Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients.","volume":"241","author":"Kotur-Stevuljevic","year":"2015","journal-title":"Atherosclerosis."},{"key":"B148","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuint.2012.11.009","article-title":"Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury.","volume":"62","author":"Manzanero","year":"2013","journal-title":"Neurochem Int."},{"key":"B149","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00508-015-0742-6","article-title":"Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome.","volume":"128","author":"Milanlioglu","year":"2016","journal-title":"Wien Klin Wochenschr."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1365-2362.2011.02546.x","article-title":"Oxidative stress in ischaemic stroke.","volume":"41","author":"Nanetti","year":"2011","journal-title":"Eur J Clin Invest."},{"key":"B151","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/sj.jhh.1001386","article-title":"Oxidative stress in malignant and non-malignant phase hypertension.","volume":"16","author":"Lip","year":"2002","journal-title":"J Hum Hypertens."},{"key":"B152","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.jhh.1001034","article-title":"Decreased endogenous antioxidant enzymatic status in essential hypertension.","volume":"14","author":"Pedro-Botet","year":"2000","journal-title":"J Hum Hypertens."},{"key":"B153","first-page":"358","article-title":"Oxidative stress and hypertension: possibility of hypertension therapy with antioxidants.","volume":"19","author":"Baradaran","year":"2014","journal-title":"J Res Med Sci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.3109\/07853890.2011.653393","article-title":"Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.","author":"Montezano","year":"2012","journal-title":"Ann Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/01.cir.103.9.1282","article-title":"Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.","volume":"103","author":"Laursen","year":"2001","journal-title":"Circulation."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/01.hjh.0000125441.28861.9f","article-title":"Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats.","volume":"22","author":"Laakso","year":"2004","journal-title":"J Hypertens."},{"key":"B157","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/CIRCRESAHA.109.214601","article-title":"Therapeutic targeting of mitochondrial superoxide in hypertension.","volume":"107","author":"Dikalova","year":"2010","journal-title":"Circ Res."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1097\/HJH.0000000000000943","article-title":"Endoplasmic reticulum stress inhibition reduces hypertension through the preservation of resistance blood vessel structure and function.","volume":"34","author":"Carlisle","year":"2016","journal-title":"J Hypertens."},{"key":"B159","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1164\/ajrccm.162.2.9908091","article-title":"Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.","author":"Schulz","year":"2000","journal-title":"Am J Respir Crit Care Med."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1378\/chest.124.4.1386","article-title":"8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.","volume":"124","author":"Carpagnano","year":"2003","journal-title":"Chest."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/eci.12338","article-title":"Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea.","volume":"44","author":"Ozben","year":"2014","journal-title":"Eur J Clin Invest."},{"key":"B162","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11325-020-02093-2","article-title":"NOX4, MDA, IMA and oxidative DNA damage: can these parameters be used to estimate the presence and severity of OSA?","volume":"25","author":"Ekin","year":"2021","journal-title":"Sleep Breath."},{"key":"B163","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11325-018-01777-0","article-title":"Short-term effects of continuous positive airway pressure on oxidative stress in severe sleep apnea.","volume":"23","author":"Tothova","year":"2019","journal-title":"Sleep Breath."},{"key":"B164","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/10715762.2011.645206","article-title":"Oxidative stress, as measured by protein oxidation, is increased in primary Sjogren\u2019s syndrome.","volume":"46","author":"Norheim","year":"2012","journal-title":"Free Radic Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/hmg\/ddt532","article-title":"Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations.","volume":"23","author":"Kim-Howard","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B166","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/10715760802623896","article-title":"Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients.","volume":"43","author":"Morgan","year":"2009","journal-title":"Free Radic Res."},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020353","article-title":"Excitotoxins, mitochondrial and redox disturbances in multiple sclerosis.","volume":"18","author":"Rajda","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B168","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11010-014-2274-1","article-title":"Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.","volume":"400","author":"Guan","year":"2015","journal-title":"Mol Cell Biochem."},{"key":"B169","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action.","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp Neurol."},{"key":"B170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease.","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adh Migr."},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113321","article-title":"Mitochondria in Alzheimer\u2019s disease and their potential role in Alzheimer\u2019s proteostasis.","volume":"330","author":"Weidling","year":"2020","journal-title":"Exp Neurol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mad.2016.05.005","article-title":"Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer\u2019s disease brain.","author":"Abolhassani","year":"2017","journal-title":"Mech Ageing Dev."},{"key":"B173","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies.","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer\u2019s disease.","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed Rep."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1089\/ars.2011.4501","article-title":"Thiol-redox signaling, dopaminergic cell death, and Parkinson\u2019s disease.","volume":"17","author":"Garcia-Garcia","year":"2012","journal-title":"Antioxid Redox Signal."},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"11","author":"Wei","year":"2018","journal-title":"Front Mol Neurosci."},{"key":"B178","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of oxidative stress in Parkinson\u2019s disease.","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp Neurobiol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease.","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.urology.2004.06.021","article-title":"Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model.","volume":"64","author":"Beshay","year":"2004","journal-title":"Urology."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1464-410X.2012.11185.x","article-title":"Reversing bladder outlet obstruction attenuates systemic and tissue oxidative stress.","volume":"110","author":"Lin","year":"2012","journal-title":"BJU Int."},{"key":"B182","doi-asserted-by":"publisher","first-page":"E221","DOI":"10.1111\/j.1464-410X.2012.11746.x","article-title":"Effect of melatonin on chronic bladder-ischaemia-associated changes in rat bladder function.","volume":"112","author":"Nomiya","year":"2013","journal-title":"BJU Int."},{"key":"B183","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/nau.20109","article-title":"Detrusor mitochondrial lipid peroxidation and superoxide dismutase activity in partial bladder outlet obstruction of rabbits.","volume":"24","author":"Lin","year":"2005","journal-title":"Neurourol Urodyn."},{"key":"B184","doi-asserted-by":"publisher","first-page":"F906","DOI":"10.1152\/ajprenal.00221.2019","article-title":"Smooth muscle-specific deletion of MnSOD exacerbates diabetes-induced bladder dysfunction in mice.","volume":"317","author":"Elrashidy","year":"2019","journal-title":"Am J Physiol Renal Physiol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.juro.2012.08.222","article-title":"Roles of polyuria and hyperglycemia in bladder dysfunction in diabetes.","volume":"189","author":"Xiao","year":"2013","journal-title":"J Urol."},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104304","article-title":"Long-term diabetes causes molecular alterations related to fibrosis and apoptosis in rat urinary bladder.","volume":"111","author":"Elrashidy","year":"2019","journal-title":"Exp Mol Pathol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"C169","DOI":"10.1152\/ajpcell.00046.2015","article-title":"Bladder function in mice with inducible smooth muscle-specific deletion of the manganese superoxide dismutase gene.","volume":"309","author":"Liu","year":"2015","journal-title":"Am J Physiol Cell Physiol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1464-410X.2007.07310.x","article-title":"Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats.","volume":"101","author":"Masuda","year":"2008","journal-title":"BJU Int."},{"key":"B189","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/nau.21191","article-title":"Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia.","volume":"31","author":"Nomiya","year":"2012","journal-title":"Neurourol Urodyn."},{"key":"B190","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1442-2042.2012.03000.x","article-title":"Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.","volume":"19","author":"Matsui","year":"2012","journal-title":"Int J Urol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.juro.2012.12.101","article-title":"Effects of coenzyme Q10 on bladder dysfunction induced by chronic bladder ischemia in a rat model.","volume":"189","author":"Kim","year":"2013","journal-title":"J Urol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.juro.2007.03.096","article-title":"Oxidative stress and neurodegeneration in the ischemic overactive bladder.","volume":"178","author":"Azadzoi","year":"2007","journal-title":"J Urol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/01.ju.0000141583.31183.7a","article-title":"Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase.","volume":"173","author":"Changolkar","year":"2005","journal-title":"J Urol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ju.0000161602.18671.c7","article-title":"Over expression of smooth muscle thin filament associated proteins in the bladder wall of diabetics.","volume":"174","author":"Mannikarottu","year":"2005","journal-title":"J Urol."},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2925985","article-title":"Regulation of spontaneous contractions in intact rat bladder strips and the effects of hydrogen peroxide.","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed Res Int."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/j.1464-410X.2010.09655.x","article-title":"Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways.","volume":"107","author":"Kanika","year":"2011","journal-title":"BJU Int."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3892\/etm.2017.5499","article-title":"Grape seed proanthocyanidin extract alleviates urethral dysfunction in diabetic rats through modulating the NO-cGMP pathway.","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med."},{"key":"B198","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/nau.20543","article-title":"External urethral sphincter activity in diabetic rats.","volume":"27","author":"Liu","year":"2008","journal-title":"Neurourol Urodyn."},{"key":"B199","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00345-020-03492-6","article-title":"A uro-protective agent with restorative actions on urethral and striated muscle morphology.","volume":"39","author":"Birder","year":"2021","journal-title":"World J Urol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/nau.23165","article-title":"Impaired contractility of the circular striated urethral sphincter muscle may contribute to stress urinary incontinence in female zucker fatty rats.","volume":"36","author":"Lee","year":"2017","journal-title":"Neurourol Urodyn."},{"key":"B201","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5213\/inj.1938050.025","article-title":"Time-dependent changes of urethral function in diabetes mellitus: a review.","volume":"23","author":"Cao","year":"2019","journal-title":"Int Neurourol J."},{"key":"B202","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.juro.2007.06.042","article-title":"Diabetic urethropathy compounds the effects of diabetic cystopathy.","volume":"178","author":"Yang","year":"2007","journal-title":"J Urol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1590\/s1677-55382012000200017","article-title":"Impact of castration with or without alpha-tocopherol supplementation on the urethral sphincter of rats.","volume":"38","author":"Kracochansky","year":"2012","journal-title":"Int Braz J Urol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejphar.2018.08.010","article-title":"Influence of the periprostatic adipose tissue in obesity-associated mouse urethral dysfunction and oxidative stress: effect of resveratrol treatment.","volume":"836","author":"Alexandre","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clinbiochem.2005.11.018","article-title":"Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.","volume":"39","author":"Aydin","year":"2006","journal-title":"Clin Biochem."},{"key":"B206","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/pros.21502","article-title":"Oxidative stress\u2013cause or consequence of male genital tract disorders?","volume":"72","author":"Kullisaar","year":"2012","journal-title":"Prostate."},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6030091","article-title":"Resveratrol: a double-edged sword in health benefits.","volume":"6","author":"Salehi","year":"2018","journal-title":"Biomedicines."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.7150\/ijms.44443","article-title":"Resveratrol reduces inflammation-related prostate fibrosis.","volume":"17","author":"Vicari","year":"2020","journal-title":"Int J Med Sci."},{"key":"B209","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ptr.2909","article-title":"Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.","volume":"24","author":"Matsumoto","year":"2010","journal-title":"Phytother Res."},{"key":"B210","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pros.23100","article-title":"Oxidative stress promotes benign prostatic hyperplasia.","volume":"76","author":"Vital","year":"2016","journal-title":"Prostate."},{"key":"B211","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000366210","article-title":"Oxidative stress in benign prostatic hyperplasia: a systematic review.","volume":"94","author":"Minciullo","year":"2015","journal-title":"Urol Int."},{"key":"B212","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/bju.12118","article-title":"The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).","volume":"112","author":"Gandaglia","year":"2013","journal-title":"BJU Int."},{"key":"B213","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1179\/1351000214Y.0000000121","article-title":"Peripheral mononuclear leukocyte DNA damage, plasma prolidase activity, and oxidative status in patients with benign prostatic hyperplasia.","volume":"20","author":"Gecit","year":"2015","journal-title":"Redox Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.812967\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T01:05:23Z","timestamp":1726794323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.812967\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":213,"alternative-id":["10.3389\/fmed.2022.812967"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.812967","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"812967"}}